Transactions classified within the Biotechnology & Medical Research sub-sector. Sectors follow a structured hierarchy so filters and comparable sets stay reproducible.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Orchestra Bio | OpenAI | Biotechnology & Medical Research (NEC) | $52.0M – $68.0M | n/m | |
| Reveal Genomics | Hologic | Bio Diagnostics & Testing | $65.0M – $88.0M | n/m | |
| Prenatal Health testing business of Myriad Genetics Inc. | LabCorp Holdings Inc. | Bio Diagnostics & Testing | $210M | 7× – 9× | |
| Atraverse Medical | Johnson & Johnson | Bio Medical Devices | $1.8M | n/m | |
| BD's Biosciences & Diagnostic Solutions business | Waters Corp. | Bio Diagnostics & Testing | $0.0M | 11× – 15× | |
| Silence Therapeutics | Merck | Bio Therapeutic Drugs | $1,300M | n/m | |
| AtaiBeckley Inc. | Eli Lilly and Company | Bio Therapeutic Drugs | $3,800M | n/m | |
| Silence Therapeutics | Merck KGaA, Darmstadt, Germany | Bio Therapeutic Drugs | $1,300M | n/m | |
| Bio-Techne | Merck KGaA | Biotechnology & Medical Research (NEC) | $11,300M | n/m | |
| Piezo Biofilm | PetVivo Holdings | Bio Medical Devices | $75.0M – $101M | 10× – 14× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.